Cardio Diagnostics Holdings (CDIO) Cash from Operations (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Cash from Operations of 1562212.0 for Q1 2026, down 14.71% sequentially from 1361849.0 in Q4 2025, and down 11.58% YoY from 1766778.88 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Cash from Operations (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Cash from Operations for 6 years, with the latest figure at 1562212.0 in Q1 2026.
- Quarterly Cash from Operations fell 11.58% year-over-year to 1562212.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5888944.0 (down 14.12% YoY) and the FY2025 annual result came in at 5726833.0, down 14.69% from the prior year.
- Cash from Operations eased to 1562212.0 in Q1 2026 per CDIO's latest filing, from 1361849.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 186090.0 in Q1 2022 and troughed at 3120265.0 in Q4 2022.
- A 5-year average of 1355605.41 and a median of 1389841.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2023: Cash from Operations tumbled 798659.2% in 2022, then surged 45.98% in 2023.
- Over 5 years, Cash from Operations stood at 3120265.0 in 2022, then surged by 45.98% to 1685677.0 in 2023, then advanced by 17.4% to 1392295.0 in 2024, then grew by 2.19% to 1361849.0 in 2025, then decreased by 14.71% to 1562212.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1562212.0, 1361849.0, and 1393418.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 728.46 Mn |
| 10 | Cardio Diagnostics Holdings | 6.07 Mn | 483,174.27 | - | -1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34 Mn |
| Jun 30, 2026 | -1.34 Mn |
| Mar 31, 2026 | -1.56 Mn |
| Mar 31, 2026 | -1.56 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.39 Mn |
| Sep 30, 2025 | -1.39 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Mar 31, 2025 | -1.40 Mn |
| Dec 31, 2024 | -1.39 Mn |
| Dec 31, 2024 | -1.39 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.23 Mn |